Who owns 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CELLDEX THERAPEUTICS INC NEW - COM Institutional Ownership

Q: What is CUSIP 015117B10?

CUSIP 015117B10 is the security identifier used in SEC filing datasets for 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM.

CUSIP: 015117B10

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2016

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 015117B10?
CUSIP 015117B10 identifies 015117B10 - CELLDEX THERAPEUTICS INC NEW - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 015117B10:

Q4 2016 (0 holders) Q3 2016 (1 holder) Q3 2015 (0 holders) Q2 2015 (1 holder) Q2 2014 (0 holders) Q1 2014 (1 holder)

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2016 Q4	0	$0	-$1,111		0
2016 Q3	274,941	$1,111	+$1,111	$0.00	1
2015 Q3	0	$0	-$405,000		0
2015 Q2	16,040	$405,000	+$405,000	$25.25	1
2014 Q2	0	$0	-$2,109		0
2014 Q1	119,364	$2,109	-$18,662	$0.02	1